The Pre-Diabetes Biomarkers identify metabolic abnormalities that may progress into diabetes. Pre-diabetes is a condition where the body cannot efficiently metabolize foods, especially carbohydrates, resulting in impaired glycemic (blood sugar) control which may progress to diabetes when not properly treated or addressed through lifestyle changes.
SpectraCell’s new Type 2 Diabetes Risk Assessment is an evaluation of specific risk factors that can indicate the presence of Pre-Diabetes and provide an assessment of a person’s risk for developing Type 2 Diabetes (Low, Moderate, or High). This test can be especially useful for identifying people within higher risk groups that are most likely to benefit from early medical and/ or lifestyle intervention. Other factors that significantly affect a pre-diabetic risk but that are not included in this report include: weight, blood pressure, smoking, inflammation, and family history.
- HDL Cholesterol
Glucose - snapshot of blood sugar at time of blood draw
Insulin - correlates to the efficiency with which a person can metabolize carbohydrates; high fasting levels indicate insulin resistance and possible pre-diabetes
Hemoglobin A1C - long term (2-3 months) marker of glycemic control; also considered a marker of accelerated aging
C-peptide - a measure of endogenous insulin production; useful in distinguishing between type 1 and type 2 diabetes
Adiponectin - a hormone that ezymatically controls metabolism; high levels beneficial and indicate efficient cellular energy production
Leptin - called the “satiety” hormone because it regulates the appetite centers in the brain to decrease hunger; chronically high levels linked to obesity and can indicate leptin resistance (dysfunctional appetite regulation)
Metabolic syndrome traits - A diagnosis of metabolic syndrome is confirmed if any three of the following six traits exist in a patient: (1) high triglycerides (2) high glucose (3) low HDL (4) high blood pressure (5) high waist circumference or (6) increased small dense LDL